Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 614

1.

Coronary Plaque Features on CTA Can Identify Patients at Increased Risk of Cardiovascular Events.

Andreini D, Magnoni M, Conte E, Masson S, Mushtaq S, Berti S, Canestrari M, Casolo G, Gabrielli D, Latini R, Marraccini P, Moccetti T, Modena MG, Pontone G, Gorini M, Maggioni AP, Maseri A; CAPIRE Investigators.

JACC Cardiovasc Imaging. 2019 Aug 8. pii: S1936-878X(19)30611-4. doi: 10.1016/j.jcmg.2019.06.019. [Epub ahead of print]

PMID:
31422137
2.

Sequencing of NOTCH1 gene in an Italian population with bicuspid aortic valve: Preliminary results from the GISSI OUTLIERS VAR study.

Pileggi S, De Chiara B, Magnoli M, Franzosi MG, Merlanti B, Bianchini F, Moreo A, Romeo G, Russo CF, Rizzo S, Basso C, Martinelli L, Maseri A; VAR Study Group.

Gene. 2019 Oct 5;715:143970. doi: 10.1016/j.gene.2019.143970. Epub 2019 Jul 19.

PMID:
31330235
3.

Effect of adherence to Mediterranean diet on first ST-elevation myocardial infarction: Insights from multiethnic case-control study.

Scarano P, Magnoni M, Vergani V, Berteotti M, Cristell N, Maseri A, Cianflone D.

Nutrition. 2019 Sep;65:185-190. doi: 10.1016/j.nut.2019.03.014. Epub 2019 Apr 3.

PMID:
31174165
4.

Modes of death and prognostic outliers in chronic heart failure.

Canepa M, Ameri P, Lucci D, Nicolosi GL, Marchioli R, Porcu M, Tognoni G, Franzosi MG, Latini R, Maseri A, Tavazzi L, Maggioni AP; GISSI-HF Investigators.

Am Heart J. 2019 Feb;208:100-109. doi: 10.1016/j.ahj.2018.11.009. Epub 2018 Nov 24.

PMID:
30580128
5.

Prognostic implications of high-sensitivity cardiac troponin T assay in a real-world population with non-ST-elevation acute coronary syndrome.

Magnoni M, Gallone G, Ceriotti F, Vergani V, Giorgio D, Angeloni G, Maseri A, Cianflone D.

Int J Cardiol Heart Vasc. 2018 Jun 19;20:14-19. doi: 10.1016/j.ijcha.2018.06.004. eCollection 2018 Sep.

6.

"Summer Shift": A Potential Effect of Sunshine on the Time Onset of ST-Elevation Acute Myocardial Infarction.

Cannistraci CV, Nieminen T, Nishi M, Khachigian LM, Viikilä J, Laine M, Cianflone D, Maseri A, Yeo KK, Bhindi R, Ammirati E.

J Am Heart Assoc. 2018 Apr 6;7(8). pii: e006878. doi: 10.1161/JAHA.117.006878.

7.

ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic-therapeutic pathway in Italy.

Gulizia MM, Colivicchi F, Ricciardi G, Giampaoli S, Maggioni AP, Averna M, Graziani MS, Ceriotti F, Mugelli A, Rossi F, Medea G, Parretti D, Abrignani MG, Arca M, Perrone Filardi P, Perticone F, Catapano A, Griffo R, Nardi F, Riccio C, Di Lenarda A, Scherillo M, Musacchio N, Panno AV, Zito GB, Campanini M, Bolognese L, Faggiano PM, Musumeci G, Pusineri E, Ciaccio M, Bonora E, Cantelli Forti G, Ruggieri MP, Cricelli C, Romeo F, Ferrari R, Maseri A.

Eur Heart J Suppl. 2017 May;19(Suppl D):D3-D54. doi: 10.1093/eurheartj/sux029. Epub 2017 May 2.

8.

Serum uric acid on admission predicts in-hospital mortality in patients with acute coronary syndrome.

Magnoni M, Berteotti M, Ceriotti F, Mallia V, Vergani V, Peretto G, Angeloni G, Cristell N, Maseri A, Cianflone D.

Int J Cardiol. 2017 Aug 1;240:25-29. doi: 10.1016/j.ijcard.2017.04.027. Epub 2017 Apr 11.

PMID:
28476518
9.

Last Word on Viewpoint: Anemia contributes to cardiovascular disease through reductions in nitric oxide.

Andreotti F, Coluzzi G, Pafundi T, Rio T, Navarese EP, Crea F, Pistolesi M, Maseri A, Hennekens CH.

J Appl Physiol (1985). 2017 Feb 1;122(2):420-421. doi: 10.1152/japplphysiol.01095.2016. No abstract available.

10.

Anemia contributes to cardiovascular disease through reductions in nitric oxide.

Andreotti F, Coluzzi G, Pafundi T, Rio T, Navarese EP, Crea F, Pistolesi M, Maseri A, Hennekens CH.

J Appl Physiol (1985). 2017 Feb 1;122(2):414-417. doi: 10.1152/japplphysiol.00995.2015. Epub 2016 Sep 29. No abstract available.

11.

[ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Consensus document. Hypercholesterolemia and cardiovascular risk: diagnostic and therapeutic pathways in Italy].

Gulizia MM, Colivicchi F, Ricciardi G, Giampaoli S, Maggioni AP, Averna M, Graziani MS, Ceriotti F, Mugelli A, Rossi F, Medea G, Parretti D, Abrignani MG, Arca M, Filardi PP, Perticone F, Catapano A, Griffo R, Nardi F, Riccio C, Di Lenarda A, Scherillo M, Musacchio N, Panno AV, Zito GB, Campanini M, Bolognese L, Faggiano PM, Musumeci G, Pusineri E, Ciaccio M, Bonora E, Cantelli Forti G, Ruggieri MP, Cricelli C, Romeo F, Ferrari R, Maseri A.

G Ital Cardiol (Rome). 2016 Jun;17(6 Suppl 1):3S-57. doi: 10.1714/2264.24358. Italian.

PMID:
27312138
12.

Applicability of the 2013 ACC/AHA Risk Assessment and Cholesterol Treatment Guidelines in the real world: results from a multiethnic case-control study.

Magnoni M, Berteotti M, Norata GD, Limite LR, Peretto G, Cristell N, Maseri A, Cianflone D.

Ann Med. 2016;48(4):282-92. doi: 10.3109/07853890.2016.1168934. Epub 2016 Apr 7.

PMID:
27052543
13.

Usefulness of High-Sensitivity Cardiac Troponin T for the Identification of Outlier Patients With Diffuse Coronary Atherosclerosis and Low-Risk Factors.

Magnoni M, Masson S, Andreini D, Moccetti T, Modena MG, Canestrari M, Berti S, Casolo G, Gabrielli D, Marraccini P, Pontone G, Latini R, Maggioni AP, Maseri A; CAPIRE Study Group.

Am J Cardiol. 2016 May 1;117(9):1397-404. doi: 10.1016/j.amjcard.2016.02.002. Epub 2016 Feb 17.

PMID:
26976791
14.

Coronary atherosclerosis in outlier subjects at the opposite extremes of traditional risk factors: Rationale and preliminary results of the Coronary Atherosclerosis in outlier subjects: Protective and novel Individual Risk factors Evaluation (CAPIRE) study.

Magnoni M, Andreini D, Gorini M, Moccetti T, Modena MG, Canestrari M, Berti S, Casolo G, Gabrielli D, Marraccini P, Pontone G, Masson S, Latini R, Maggioni AP, Maseri A; CAPIRE Study Group.

Am Heart J. 2016 Mar;173:18-26. doi: 10.1016/j.ahj.2015.11.017. Epub 2015 Dec 17.

PMID:
26920592
15.

Anti-TNFα agents curb platelet activation in patients with rheumatoid arthritis.

Manfredi AA, Baldini M, Camera M, Baldissera E, Brambilla M, Peretti G, Maseri A, Rovere-Querini P, Tremoli E, Sabbadini MG, Maugeri N.

Ann Rheum Dis. 2016 Aug;75(8):1511-20. doi: 10.1136/annrheumdis-2015-208442. Epub 2016 Jan 27.

PMID:
26819099
16.

Granulocyte-colony stimulating factor for large anterior ST-elevation myocardial infarction: rationale and design of the prospective randomized phase III STEM-AMI OUTCOME trial.

Achilli F, Malafronte C, Cesana F, Maggiolini S, Mauro C, De Ferrari GM, Lenatti L, Tespili M, Pasqualini P, Gentile F, Capogrossi MC, Maggioni A, Maseri A, Pontone G, Colombo GI, Pompilio G; STEM-AMI OUTCOME Trial Investigators.

Am Heart J. 2015 Oct;170(4):652-658.e7. doi: 10.1016/j.ahj.2015.07.005. Epub 2015 Jul 12.

PMID:
26386788
17.

Rationale and design of GISSI OUTLIERS VAR Study in bicuspid aortic valve patients: prospective longitudinal, multicenter study to investigate correlation between surgical, echo distinctive features, histologic and genetic findings in phenotypically homogeneous outlier cases.

Merlanti B, De Chiara B, Maggioni AP, Moreo A, Pileggi S, Romeo G, Russo CF, Rizzo S, Martinelli L, Maseri A; VAR Study Group.

Int J Cardiol. 2015 Nov 15;199:180-5. doi: 10.1016/j.ijcard.2015.06.182. Epub 2015 Jul 6.

PMID:
26197404
18.

Foreword of the President of the Fondazione per il Tuo Cuore (Heart Care Foundation), Florence.

Maseri A.

Eur J Prev Cardiol. 2015 Sep;22(2 Suppl):8. doi: 10.1177/2047487315591140. No abstract available.

PMID:
26195611
19.

Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps.

Maugeri N, Campana L, Gavina M, Covino C, De Metrio M, Panciroli C, Maiuri L, Maseri A, D'Angelo A, Bianchi ME, Rovere-Querini P, Manfredi AA.

J Thromb Haemost. 2014 Dec;12(12):2074-88. doi: 10.1111/jth.12710. Epub 2014 Nov 14.

20.

Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study.

Rutten B, Maseri A, Cianflone D, Laricchia A, Cristell NA, Durante A, Spartera M, Ancona F, Limite L, Hu D, Li H, Uren NG, de Groot PG, Mannucci PM, Roest M.

Eur Heart J Acute Cardiovasc Care. 2015 Feb;4(1):64-74. doi: 10.1177/2048872614534388. Epub 2014 May 15.

PMID:
24833640
21.

Letter by Ammirati and Maseri regarding article, "Bacterial signatures in thrombus aspirates of patients with myocardial infarction".

Ammirati E, Maseri A.

Circulation. 2013 Oct 8;128(15):e235. doi: 10.1161/CIRCULATIONAHA.113.002860. No abstract available.

PMID:
24100486
22.

Still need for compelling evidence to support the circadian dependence of infarct size after ST-elevation myocardial infarction.

Ammirati E, Maseri A, Cannistraci CV.

Circ Res. 2013 Aug 2;113(4):e43-4. doi: 10.1161/CIRCRESAHA.113.301908. No abstract available.

PMID:
23908336
23.

A "stable" coronary plaque rupture documented by repeated OCT studies.

Di Vito L, Prati F, Arbustini E, Crea F, Maseri A.

JACC Cardiovasc Imaging. 2013 Jul;6(7):835-6. doi: 10.1016/j.jcmg.2012.12.012. Epub 2013 May 8. No abstract available.

24.

Questing for circadian dependence in ST-segment-elevation acute myocardial infarction: a multicentric and multiethnic study.

Ammirati E, Cristell N, Cianflone D, Vermi AC, Marenzi G, De Metrio M, Uren NG, Hu D, Ravasi T, Maseri A, Cannistraci CV.

Circ Res. 2013 May 10;112(10):e110-4. doi: 10.1161/CIRCRESAHA.112.300778.

PMID:
23661713
25.

C-reactive protein, fibrinogen, and cardiovascular risk.

Ammirati E, Maseri A.

N Engl J Med. 2013 Jan 3;368(1):85. doi: 10.1056/NEJMc1213688. No abstract available.

PMID:
23281990
26.

Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models.

Ammirati E, Cianflone D, Vecchio V, Banfi M, Vermi AC, De Metrio M, Grigore L, Pellegatta F, Pirillo A, Garlaschelli K, Manfredi AA, Catapano AL, Maseri A, Palini AG, Norata GD.

J Am Heart Assoc. 2012 Feb;1(1):27-41. doi: 10.1161/JAHA.111.000125. Epub 2012 Feb 20.

27.

Molecular study of human herpesvirus 6 and 8 involvement in coronary atherosclerosis and coronary instability.

Magnoni M, Malnati M, Cristell N, Coli S, Russo D, Ruotolo G, Cianflone D, Alfieri O, Lusso P, Maseri A.

J Med Virol. 2012 Dec;84(12):1961-6. doi: 10.1002/jmv.23355.

PMID:
23080503
28.

Safety of provocative tests of coronary artery spasm and prediction of long-term outcome: need for an innovative clinical research strategy.

Maseri A.

Eur Heart J. 2013 Jan;34(4):252-4. doi: 10.1093/eurheartj/ehs312. Epub 2012 Sep 24. No abstract available.

PMID:
23008507
29.

Identification and predictive value of interleukin-6+ interleukin-10+ and interleukin-6- interleukin-10+ cytokine patterns in ST-elevation acute myocardial infarction.

Ammirati E, Cannistraci CV, Cristell NA, Vecchio V, Palini AG, Tornvall P, Paganoni AM, Miendlarzewska EA, Sangalli LM, Monello A, Pernow J, Björnstedt Bennermo M, Marenzi G, Hu D, Uren NG, Cianflone D, Ravasi T, Manfredi AA, Maseri A.

Circ Res. 2012 Oct 26;111(10):1336-48. doi: 10.1161/CIRCRESAHA.111.262477. Epub 2012 Aug 29.

PMID:
22931953
30.

Cross-reacting antibacterial auto-antibodies are produced within coronary atherosclerotic plaques of acute coronary syndrome patients.

Canducci F, Saita D, Foglieni C, Piscopiello MR, Chiesa R, Colombo A, Cianflone D, Maseri A, Clementi M, Burioni R.

PLoS One. 2012;7(8):e42283. doi: 10.1371/journal.pone.0042283. Epub 2012 Aug 6.

31.

An intense and short-lasting burst of neutrophil activation differentiates early acute myocardial infarction from systemic inflammatory syndromes.

Maugeri N, Rovere-Querini P, Evangelista V, Godino C, Demetrio M, Baldini M, Figini F, Coppi G, Slavich M, Camera M, Bartorelli A, Marenzi G, Campana L, Baldissera E, Sabbadini MG, Cianflone D, Tremoli E, D'Angelo A, Manfredi AA, Maseri A.

PLoS One. 2012;7(6):e39484. doi: 10.1371/journal.pone.0039484. Epub 2012 Jun 25.

32.

[The PROSPECT study].

Maseri A, Prati F, Ammirati E.

G Ital Cardiol (Rome). 2012 Mar;13(3):143-6. doi: 10.1714/1038.11318. Italian. No abstract available.

PMID:
22395104
33.

High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study.

Cristell N, Cianflone D, Durante A, Ammirati E, Vanuzzo D, Banfi M, Calori G, Latib A, Crea F, Marenzi G, De Metrio M, Moretti L, Li H, Uren NG, Hu D, Maseri A; FAMI Study Investigators.

J Am Coll Cardiol. 2011 Dec 13;58(25):2654-61. doi: 10.1016/j.jacc.2011.08.055.

34.

An inverted location of the bicuspid valve disease: a variant of a variant.

Magnoni M, Turri C, Roghi A, Merlanti B, Maseri A.

Circulation. 2011 Nov 15;124(20):e513-5. doi: 10.1161/CIRCULATIONAHA.111.055285. No abstract available.

PMID:
22083150
35.

Polycythemia, vascular function, and hemoglobin-nitric oxide reactions.

Andreotti F, Pafundi T, Crea F, Coluzzi G, Maseri A.

J Appl Physiol (1985). 2011 Jul;111(1):331; author reply 332. doi: 10.1152/japplphysiol.00365.2011. No abstract available.

36.

Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction.

Maugeri N, Rovere-Querini P, Slavich M, Coppi G, Doni A, Bottazzi B, Garlanda C, Cianflone D, Maseri A, Mantovani A, Manfredi AA.

J Immunol. 2011 Jul 15;187(2):970-9. doi: 10.4049/jimmunol.1100261. Epub 2011 Jun 15. Erratum in: J Immunol. 2011 Dec 15;187(12):6582.

37.

A natural-history study of coronary disease.

Maseri A, Ammirati E, Prati F.

N Engl J Med. 2011 Apr 14;364(15):1469; author reply 1471-2. doi: 10.1056/NEJMc1101916. No abstract available.

PMID:
21488777
38.

Hemoglobin levels, nitric oxide bioavailability and cardiovascular outcomes.

Andreotti F, Pafundi T, Coluzzi G, Maseri A.

Am J Cardiol. 2011 Apr 1;107(7):1099; author reply 1099-100. doi: 10.1016/j.amjcard.2010.12.028. No abstract available.

PMID:
21419890
39.

Assessment of Takayasu arteritis activity by carotid contrast-enhanced ultrasound.

Magnoni M, Dagna L, Coli S, Cianflone D, Sabbadini MG, Maseri A.

Circ Cardiovasc Imaging. 2011 Mar;4(2):e1-2. doi: 10.1161/CIRCIMAGING.110.960906. No abstract available.

PMID:
21406658
40.

[The evolution of medical research: from trials to tailored therapy].

Pasini E, Pirelli S, Di Lenarda A, Dioguardi FS, Maseri A.

G Ital Cardiol (Rome). 2010 Oct;11(10):761-6. Review. Italian.

PMID:
21246777
41.

The tako-tsubo cardiomyopathy syndrome: lumpers or splitters?

Maseri A.

J Cardiovasc Med (Hagerstown). 2010 Jun;11(6):402-3. doi: 10.2459/JCM.0b013e32833664aa. No abstract available.

PMID:
20421758
42.

Clinical and experimental evidences on the prothrombotic properties of neutrophils.

Maugeri N, Manfredi AA, Maseri A.

Srp Arh Celok Lek. 2010 Jan;138 Suppl 1:50-2. Review.

43.

Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease?

Prezioso L, Tanzi S, Galaverna F, Frati C, Testa B, Savi M, Graiani G, Lagrasta C, Cavalli S, Galati S, Madeddu D, Lodi Rizzini E, Ferraro F, Musso E, Stilli D, Urbanek K, Piegari E, De Angelis A, Maseri A, Rossi F, Quaini E, Quaini F.

Cardiovasc Hematol Agents Med Chem. 2010 Jan;8(1):55-75. Review.

PMID:
20210776
44.

Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome.

Langheim S, Dreas L, Veschini L, Maisano F, Foglieni C, Ferrarello S, Sinagra G, Zingone B, Alfieri O, Ferrero E, Maseri A, Ruotolo G.

Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H746-53. doi: 10.1152/ajpheart.00617.2009. Epub 2010 Jan 8.

45.

IMAGE CARDIO MED: Two different mechanisms of myocardial ischemia involving 2 separate myocardial segments in a patient with normal coronary angiography.

Magnoni M, Esposito A, Coli S, Scuteri L, De Cobelli F, Cianflone D, Del Maschio A, Maseri A.

Circulation. 2010 Jan 5;121(1):e1-3. doi: 10.1161/CIRCULATIONAHA.109.878314. No abstract available.

PMID:
20048228
46.

Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents.

Chieffo A, Foglieni C, Nodari RL, Briguori C, Sangiorgi G, Latib A, Montorfano M, Airoldi F, Michev I, Carlino M, Colombo A, Maseri A.

Am J Cardiol. 2009 Dec 15;104(12):1660-7. doi: 10.1016/j.amjcard.2009.07.041.

PMID:
19962471
47.

[New targets for prevention: identification of specific disease mechanisms].

Maseri A.

G Ital Cardiol (Rome). 2009 Dec;10(11-12 Suppl 3):39S-42S. Italian.

PMID:
21298861
48.

Leukocyte and platelet activation in patients with giant cell arteritis and polymyalgia rheumatica: a clue to thromboembolic risks?

Maugeri N, Baldini M, Rovere-Querini P, Maseri A, Sabbadini MG, Manfredi AA.

Autoimmunity. 2009 May;42(4):386-8.

PMID:
19811309
49.

Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques.

Burioni R, Canducci F, Saita D, Perotti M, Mancini N, De Marco D, Clementi N, Chieffo A, Denaro M, Cianflone D, Manfredi AA, Colombo A, Maseri A, Clementi M.

J Immunol. 2009 Aug 15;183(4):2537-44. doi: 10.4049/jimmunol.0901076. Epub 2009 Jul 27.

50.

Combination of variant and microvascular angina.

Infusino F, Lanza GA, Sestito A, Sgueglia GA, Crea F, Maseri A.

Clin Cardiol. 2009 Aug;32(8):E40-5. doi: 10.1002/clc.20502.

Supplemental Content

Loading ...
Support Center